Atienza Josephine M, Yu Naichen, Kirstein Shelli L, Xi Biao, Wang Xiaobo, Xu Xiao, Abassi Yama A
ACEA Biosciences Inc., San Diego, CA 92121, USA.
Assay Drug Dev Technol. 2006 Oct;4(5):597-607. doi: 10.1089/adt.2006.4.597.
Cell-based assays have become an integral part of the preclinical drug development process. Recently, noninvasive label-free cell-based assay technologies have taken center stage, offering important and distinct advantages over and in addition to traditional label-based endpoint assays. Dynamic monitoring of live cells, the preclusion of label, and kinetics are some of the fundamental features of cell-based label-free technologies. In this article we will discuss the real-time cell electronic sensing (RT-CES, ACEA Biosciences Inc., San Diego, CA) system and some of its key applications for cell-based assays such as cell proliferation and cytotoxicity, functional assays for receptor-ligand analysis, cell adhesion and spreading assays, dynamic monitoring of endothelial barrier function, and dynamic monitoring of cell migration and invasion. Also, where appropriate we will briefly discuss other label-free technologies in an application-specific manner.
基于细胞的检测已成为临床前药物开发过程中不可或缺的一部分。最近,非侵入性无标记基于细胞的检测技术成为焦点,与传统的基于标记的终点检测相比,具有重要且独特的优势。对活细胞进行动态监测、无需标记以及动力学分析是基于细胞的无标记技术的一些基本特征。在本文中,我们将讨论实时细胞电子传感(RT-CES,ACEA生物科学公司,加利福尼亚州圣地亚哥)系统及其在基于细胞的检测中的一些关键应用,如细胞增殖和细胞毒性检测、受体-配体分析的功能检测、细胞黏附与铺展检测、内皮屏障功能的动态监测以及细胞迁移和侵袭的动态监测。此外,我们还将在适当的地方以特定应用的方式简要讨论其他无标记技术。